Home Tags Life sciences

Tag: life sciences

IlluminOss breakthrough lands it in the biotech marketplace

For years regional business and governmental leaders have been touting the potential here for breakthrough life sciences and biotechnology ventures. This week, one of...
RI BIO AND the Rhode Island BioHub Group’s collaborative report on the state’s life sciences industry indicated that the sector was held back by fragmented and uncoordinated resources. The report also recommended RI Bio as an organizing force among other suggestions intended to help the industry reach its potential in Rhode Island.

RI Bio, Rhode Island BioHub Group chart local life science industry...

PROVIDENCE — The state’s life sciences industry has been held back by fragmented and uncoordinated resources, according to a collaborative report  from the biotechnology...

R.I. Hospital study investigates if drug can slow, improve Alzheimer’s symptoms

PROVIDENCE – Rhode Island Hospital researchers are seeking subjects for a Phase 2 study into whether an investigational drug, Troriluzole, a new version of...
THOMAS SEEWOESTER has replaced Tia Bush as Amgen's vice president of site operations for its Rhode Island and Woburn, Mass., facilities. Bush has taken on the role of senior vice president of quality at the company's headquarters in Thousand Oaks, Calif. / COURTESY AMGEN INC.

Seewoester replaces Bush as Amgen VP of site operations for R.I.,...

PROVIDENCE – Tia Bush has moved on from her role as Amgen Inc.’s vice president of site operations, Rhode Island and Woburn, Mass., to...
RUBIUS THERAPEUTICS reported a $26.4 million loss for the third quarter. The company does not yet generate revenue.

Rubius reports $26.4M loss for Q3

PROVIDENCE – Cambridge, Mass.-headquartered Rubius Therapeutics Inc. announced a $26.4 million net loss for the third quarter of 2018 Tuesday. The company reported an...
AT THE CONSTRUCTION site of the Wexford Innovation Center in Providence are, from left, Dan Bagnall, project supervisor, Shawmut Design and Construction; Beverly Smith, client service manager, Shawmut; Sean Lee Burgo, project director for construction, Wexford Science & Technology; and Chi Yik, project manager, Shawmut. A parcel of land in the Interstate 195 Redevelopment District will be converted to temporary parking for tenants of the Wexford center, scheduled to open by June. / PBN FILE PHOTO/MICHAEL SALERNO

PBN on WJAR-TV, Nov. 12, 2018

Despite false starts, transformation of Jewelry District taking shape. Every week, PBN Editor Mark S. Murphy appears on WJAR-TV NBC 10’s Coffee Break to discuss...
Patrice M. Milos has been a leader in the life sciences for nearly three decades and has lived in Rhode Island since 1989. But until co-founding Medley Genomics roughly two years ago, she had been saddled with time-consuming commutes 
to work, an experience that informed her current position.  / PBN PHOTO/DAVE HANSEN

Finding purpose, passion, people and finally place here in Rhode Island

Patrice M. Milos | Medley Genomics Inc. co-founder, president and CEOOver the course of my 25-year life sciences career, I have been fortunate to...
THE MIRIAM HOSPITAL has received a $9.4 million grant from the National Institutes of Health to establish the Center for Antimicrobial Resistance and Therapeutic Discovery to research "superbugs" and to look for potential new drugs. / COURTESY LIFESPAN

The Miriam Hospital receives $9.4M grant to study antibiotic resistance

PROVIDENCE – The Miriam Hospital has received a five-year, $9.4 million grant from the National Institutes of Health to create an NIH Center for...
DR. JOSIAH RICH will be the pricipal investigator at the Center of Biomedical Research Excellence on Opioids and Overdose at Rhode Island Hospital. The COBRE project has been granted $11.8 million in a phase I grant from the National Institutes of General Medical Sciences. / COURTESY LIFESPAN

R.I. Hospital receives $11.8M federal grant to establish opioid research center

PROVIDENCE – Rhode Island Hospital has received an $11.8 million federal grant to address the opioid epidemic by establishing the Center of Biomedical Research...

Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield

SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to...
- Featured Event -

Latest News

For a limited time, Providence Business News is offering free access to all its online content. See what you have been missing on PBN.com, including news, in-depth reporting, commentary, lists and more.